D75.839
Thrombocytosis, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Thrombocythemia NOS
- Thrombocytosis NOS
Medical Intelligence & Overview
Thrombocytosis, also known as thrombocythemia, is a condition characterized by an elevated number of platelets in the blood. Platelets are small cell fragments that help blood clot, preventing bleeding. When their count exceeds normal levels, it can lead to health issues such as blood clots or bleeding problems. The ICD-10 code D75.839 refers to an unspecified form of thrombocytosis, meaning the exact type or cause has not been detailed. While sometimes a temporary response to another condition, persistent thrombocytosis requires medical assessment to determine the appropriate management.
Causes & Symptoms
Clinical Causes: Reactive (or secondary) thrombocytosis due to underlying conditions, such as infections, inflammation, trauma, or iron deficiency anemia. Myeloproliferative disorders, such as essential thrombocythemia, where the bone marrow produces too many platelets. Certain cancers, including lung, gastrointestinal, or breast cancers, which can trigger increased platelet production. Recovery phases following an illness or surgery, where platelet levels temporarily rise. Splenectomy (removal of the spleen), which can contribute to higher platelet counts. Chronic inflammatory diseases, such as rheumatoid arthritis or inflammatory bowel disease. Certain medications or treatments that affect bone marrow function.
Key Symptoms: Often no symptoms are present, especially in mild cases. In some cases, symptoms may include headache, dizziness, or a feeling of fullness in the spleen area. Increased risk of blood clots, which might lead to conditions like deep vein thrombosis (DVT) or pulmonary embolism. Bleeding tendencies in some individuals due to abnormal platelet function. Red or purple skin patches in cases of thrombocytosis caused by blood clots or bleeding issues. Enlarged spleen or liver in more advanced cases. Weakness or fatigue in some individuals.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests, with a complete blood count (CBC) revealing elevated platelet levels. Additional tests may be ordered to determine the underlying cause, such as bone marrow biopsy, genetic testing, or assessment for signs of reactive processes. It’s essential to differentiate between primary thrombocytosis (related to bone marrow disorders) and secondary causes related to other health conditions.
Treatment Protocols: Treatment approaches depend on the underlying cause, severity, and individual health factors. In cases of reactive thrombocytosis, managing the primary condition often suffices. For primary thrombocytosis, treatments may include medications to reduce platelet count, such as hydroxyurea or anagrelide, and low-dose aspirin to prevent blood clots. Regular monitoring of platelet levels and blood activity is typically recommended. In some situations, procedures like platelet apheresis are considered to quickly lower counts. Lifestyle modifications, including maintaining a healthy blood pressure and avoiding smoking, can also support management, but specific treatment plans should always be discussed with a healthcare professional.
Clinical Advice & FAQs
Billing Guidance
Is D75.839 a billable ICD-10 code?
Yes, D75.839 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D75.839?
Clinical documentation must specify the nature of Thrombocytosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
